Drug Shortage Report for APO-MOXIFLOXACIN
Report ID | 97474 |
Drug Identification Number | 02406373 |
Brand name | APO-MOXIFLOXACIN |
Common or Proper name | MOXIFLOXACIN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | MOXIFLOXACIN |
Strength(s) | 0.5% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 3 ML |
ATC code | S01AE |
ATC description | ANTIINFECTIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-28 |
Estimated end date | 2020-03-06 |
Actual end date | 2020-03-06 |
Shortage status | Resolved |
Updated date | 2020-03-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2020-03-09 | French | Compare |
v11 | 2020-03-09 | English | Compare |
v10 | 2020-01-31 | French | Compare |
v9 | 2020-01-31 | English | Compare |
v8 | 2020-01-07 | French | Compare |
v7 | 2020-01-07 | English | Compare |
v6 | 2019-12-19 | French | Compare |
v5 | 2019-12-19 | English | Compare |
v4 | 2019-12-04 | French | Compare |
v3 | 2019-12-04 | English | Compare |
v2 | 2019-10-30 | French | Compare |
v1 | 2019-10-30 | English | Compare |
Showing 1 to 12 of 12